European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest

Jasmeet Soar, Gavin D. Perkins, Ian Maconochie, Bernd W. Böttiger, Charles D. Deakin, Claudio Sandroni, Theresa M. Olasveengen, Jonathan Wyllie, Robert Greif, Andrew Lockey, Federico Semeraro, Patrick Van De Voorde, Carsten Lott, Leo Bossaert, Koenraad G. Monsieurs, Jerry P. Nolan

Risultato della ricerca: Contributo in rivistaArticolo in rivista

25 Citazioni (SciVal)

Abstract

This European Resuscitation Council (ERC) Guidelines for Resuscitation 2018 update is focused on the role of antiarrhythmic drugs during advanced life support for cardiac arrest with shock refractory ventricular fibrillation/pulseless ventricular tachycardia in adults, children and infants. This update follows the publication of the International Liaison Committee on Resuscitation (ILCOR) 2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations (CoSTR). The ILCOR CoSTR suggests that any beneficial effects of amiodarone or lidocaine are similar. This ERC update does not make any major changes to the recommendations for the use of antiarrhythmic drugs during advanced life support for shock refractory cardiac arrest.
Lingua originaleEnglish
pagine (da-a)99-103
Numero di pagine5
RivistaResuscitation
Volume134
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Advanced life support
  • Amiodarone
  • Antiarrhythmic drugs
  • Cardiology and Cardiovascular Medicine
  • Cardiopulmonary resuscitation
  • Emergency Medicine
  • Emergency Nursing
  • Guidelines
  • Heart arrest
  • Lidocaine
  • Neonatal life support
  • Paediatric life support
  • Pulseless ventricular tachycardia
  • Ventricular fibrillation

Fingerprint

Entra nei temi di ricerca di 'European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest'. Insieme formano una fingerprint unica.

Cita questo